Table 1.
Clinical characteristics of HD participants and controls
| HD | Controls | |
|---|---|---|
|
Age |
45.3±10.7 |
45.45±11.1 |
| |
(26–68) |
(26–68) |
|
Sex (male/female) |
21/21 |
21/21 |
|
Age of onseta) |
39.0±11.3 |
|
|
motor symptoms |
(20–63) |
- |
|
Age of onset |
38.0±11.1 |
|
|
psychiatric symptomsb) |
(20–63) |
- |
|
Duration of motor symptomsa) |
7.31±3.72 |
- |
| |
(2–18) |
|
|
Duration of psychiatric |
7.72±4.67 |
- |
|
symptomsb) |
(1–22) |
|
|
UHDRS MS |
45.3±21.1 |
- |
| |
(0–81) |
|
|
UHDRS TFC |
7.5±3.2 |
- |
| |
(2–13) |
|
|
UHDRS IS |
70.0±16.5 |
- |
| |
(30–100) |
|
|
MMSE |
24.4±6.4 |
- |
| (11–35) |
Values are given as mean and standard deviation, as well as the range in brackets. Abbreviations: UHDRS, unified Huntington’s disease rating scale; IS, independence scale; TFC, total functional capacity; MS, motor score; MMSE, mini-mental state examination. Missing data for the three premanifest participantsa); Missing data for 11 participantsb).